41.35
Inspire Medical Systems Inc stock is traded at $41.35, with a volume of 700.09K.
It is down -2.96% in the last 24 hours and down -5.68% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
See More
Previous Close:
$42.61
Open:
$42.3
24h Volume:
700.09K
Relative Volume:
0.64
Market Cap:
$1.19B
Revenue:
$915.25M
Net Income/Loss:
$131.14M
P/E Ratio:
9.2464
EPS:
4.472
Net Cash Flow:
$96.71M
1W Performance:
+0.53%
1M Performance:
-5.68%
6M Performance:
-57.78%
1Y Performance:
-68.41%
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INSP
Inspire Medical Systems Inc
|
41.35 | 1.23B | 915.25M | 131.14M | 96.71M | 4.472 |
|
ABT
Abbott Laboratories
|
87.83 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
304.69 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
79.27 | 101.56B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.33 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.88 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-12-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-12-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-26 | Downgrade | Truist | Buy → Hold |
| Dec-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-26-25 | Upgrade | Truist | Hold → Buy |
| Nov-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-24-25 | Upgrade | Stifel | Hold → Buy |
| Nov-04-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-24-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
INSP Highlights New OSA Data and PREDICTOR Study at SLEEP 2026 - Yahoo Finance
Assessing Inspire Medical Systems (INSP) Valuation After A Prolonged Share Price Slide - Sahm
Inspire Medical Systems Inc (INSP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inspire Medical Systems Inc (INSP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inspire Medical Systems Inc (INSP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inspire Medical Systems Inc (INSP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inspire Medical Systems Inc (INSP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Inspire Medical Systems Inc (INSP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Inspire Medical Systems Inc (INSP) Institutional Confidence - TradingKey
Inspire Medical Systems Inc (INSP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inspire Medical Systems Inc (INSP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Inspire Medical data highlights cardiovascular outcomes with neuromod for sleep apnea - MassDevice
Inspire Medical Systems, Inc. Announces Presence At SLEEP 2026 And Highlights New Clinical Data, Technology Advancements, And Cardiovascular Outcomes Research - marketscreener.com
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study - marketscreener.com
Discipline and Rules-Based Execution in INSP Response - Stock Traders Daily
Oppenheimer reiterates Perform on Inspire Medical stock amid challenges By Investing.com - Investing.com Canada
Inspire Medical Systems, Inc. (INSP): Growth Potential and Investor Outlook in the Healthcare Sector - DirectorsTalk Interviews
INSP Technical Analysis & Stock Price Forecast - Intellectia AI
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight - The Manila Times
Inspire Medical to discuss sleep apnea tech at Wells Fargo MedTech event - Stock Titan
Alphatec vs. Inspire Medical Systems: Investment Profiles in Medical DevicesNews and Statistics - IndexBox
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
Inspire Medical Systems (INSP) Q1 earnings and revenues top estimates - MSN
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Healthcare Sector with a 26.65% Potential Upside - DirectorsTalk Interviews
Inspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced Selloff - Seeking Alpha
Behavioral Patterns of INSP and Institutional Flows - Stock Traders Daily
Inspire Medical Systems Hits 52-Week Low at $39.29 Amidst Major Decline - Markets Mojo
Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report? - Yahoo Finance
Is Inspire Medical Systems (INSP) Reset Creating A Potential Opportunity For Investors Now - Yahoo Finance
Inspire Medical Systems stock hits 52-week low at 39.51 USD - Investing.com Canada
Inspire Medical Systems stock hits 52-week low at 39.51 USD By Investing.com - Investing.com South Africa
Inspire Medical Deadline Reminder - TMX Newsfile
Mairs & Power Small Cap Fund's Inspire Medical Systems Inc(INSP) Holding History - GuruFocus
Can Inspire Medical Systems (INSP) Convert Revenue Beats Into Sustainable Earnings Strength? - Sahm
Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Healthcare Innovator with 26% Potential Upside - DirectorsTalk Interviews
Cash Machine Trading Cheap – Inspire Medical Systems Stock Set to Run? - Trefis
Inspire Medical Systems Stock: Strong Cash Flow Poised for a Re-Rating? - Trefis
Inspire Medical Systems Inc (INSP) Shares Fall 4.0% -- What GF S - GuruFocus
Spotting Winners: Inspire Medical Systems (NYSE:INSP) And Medical Devices & SuppliesSpecialty Stocks In Q1 - Yahoo Finance
INSP Stock Price, Quote & Chart | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
What Does Stifel Think About Inspire Medical (INSP) After a Guidance Cut That Surprised Wall Street? - Insider Monkey
Soleus files 1.47M-share stake in Inspire Medical Systems (INSP) - Stock Titan
Analyst warns Inspire Medical has a problem lasting into 2028 - thestreet.com
Inspire Medical Systems (INSP) Cuts 2026 Outlook Amid Medicare Uncertainty and Insider Sale – What’s Changed? - Sahm
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unveiling a Potential 18.99% Upside in the Healthcare Sector - DirectorsTalk Interviews
A Look At Inspire Medical Systems (INSP) Valuation As Analyst Caution Rises On Reimbursement Coding Risks - Sahm
(INSP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Inspire Medical drops as BofA cuts to underperform on lack of coding clarity - MSN
Here's why you should add Inspire Medical stock to your portfolio now - MSN
BofA Securities Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Cuts Target Price to $39 - Moomoo
Inspire Medical Systems (INSP) price target decreased by 17.14% to 72.73 - MSN
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):